MXPA04004743A - Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina. - Google Patents

Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina.

Info

Publication number
MXPA04004743A
MXPA04004743A MXPA04004743A MXPA04004743A MXPA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A MX PA04004743 A MXPA04004743 A MX PA04004743A
Authority
MX
Mexico
Prior art keywords
neurotensin
diaryl
active
pyrazolidine derivatives
formula
Prior art date
Application number
MXPA04004743A
Other languages
English (en)
Inventor
Hiskias G Keizer
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of MXPA04004743A publication Critical patent/MXPA04004743A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/04Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invencion describe un grupo de derivados de 2,3-diaril-piparazolidina novedosos que tienen formula (1); ver formula (1) lo simbolos usados en la formula (1) tienen los significados dados en la especificacion; los compuestos tienen la actividad inhibidora en enzimas que degradan el neuropeptido neurotensina y se pueden usar en el tratamiento de afecciones y enfermedades provocadas por disturbios de la transmision mediada por neurotensina.
MXPA04004743A 2002-03-18 2003-03-17 Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina. MXPA04004743A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076482 2002-03-18
PCT/EP2003/050064 WO2003078400A1 (en) 2002-03-18 2003-03-17 Neurotensin active 2,3-diaryl-pyrazolidine derivatives

Publications (1)

Publication Number Publication Date
MXPA04004743A true MXPA04004743A (es) 2004-08-02

Family

ID=27838122

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004743A MXPA04004743A (es) 2002-03-18 2003-03-17 Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina.

Country Status (25)

Country Link
US (1) US7186741B2 (es)
EP (1) EP1487802B1 (es)
JP (1) JP4484525B2 (es)
KR (1) KR20040106290A (es)
CN (1) CN100509788C (es)
AR (1) AR038967A1 (es)
AT (1) ATE493390T1 (es)
AU (1) AU2003219165B2 (es)
BR (1) BR0306149A (es)
CA (1) CA2462694C (es)
DE (1) DE60335525D1 (es)
DK (1) DK1487802T3 (es)
ES (1) ES2358894T3 (es)
HK (1) HK1070646A1 (es)
HR (1) HRP20040275A2 (es)
IL (1) IL160944A0 (es)
MX (1) MXPA04004743A (es)
NO (1) NO20044405L (es)
PL (1) PL371440A1 (es)
PT (1) PT1487802E (es)
RU (1) RU2304578C2 (es)
SI (1) SI1487802T1 (es)
UA (1) UA77775C2 (es)
WO (1) WO2003078400A1 (es)
ZA (1) ZA200404741B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1801098A1 (en) 2005-12-16 2007-06-27 Merck Sante 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
CN102241678B (zh) 2011-04-26 2014-10-29 辽宁利锋科技开发有限公司 含有脂环结构化合物的抗肿瘤作用与应用
BR112016028119A2 (pt) 2014-06-06 2017-08-22 Res Triangle Inst Agonistas receptores de apelina (apj) e usos dos mesmos
EP3386976A1 (en) 2015-12-09 2018-10-17 Research Triangle Institute, International Improved apelin receptor (apj) agonists and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712365A1 (de) * 1987-04-11 1988-10-27 Hoechst Ag Neue 2-acylpyrrolidin-derivate, verfahren zu ihrer herstellung, sie enthaltende mittel sowie deren verwendung
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2665898B1 (fr) * 1990-08-20 1994-03-11 Sanofi Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2711140B1 (fr) * 1993-10-12 1996-01-05 Sanofi Sa 1-Naphtylpyrazole-3-carboxamides substitués actifs sur la neurotensine, leur préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
PT1487802E (pt) 2011-03-11
PL371440A1 (en) 2005-06-13
CN1592742A (zh) 2005-03-09
EP1487802A1 (en) 2004-12-22
EP1487802B1 (en) 2010-12-29
WO2003078400A1 (en) 2003-09-25
AU2003219165A1 (en) 2003-09-29
ATE493390T1 (de) 2011-01-15
DK1487802T3 (da) 2011-04-04
UA77775C2 (en) 2007-01-15
NO20044405L (no) 2004-10-15
RU2004114262A (ru) 2005-09-20
US7186741B2 (en) 2007-03-06
AU2003219165B2 (en) 2008-03-13
SI1487802T1 (sl) 2011-04-29
HK1070646A1 (en) 2005-06-24
HRP20040275A2 (en) 2004-08-31
CA2462694A1 (en) 2003-09-25
AR038967A1 (es) 2005-02-02
US20040242493A1 (en) 2004-12-02
CN100509788C (zh) 2009-07-08
BR0306149A (pt) 2004-10-19
IL160944A0 (en) 2004-08-31
ES2358894T3 (es) 2011-05-16
JP2005527528A (ja) 2005-09-15
KR20040106290A (ko) 2004-12-17
JP4484525B2 (ja) 2010-06-16
DE60335525D1 (de) 2011-02-10
RU2304578C2 (ru) 2007-08-20
CA2462694C (en) 2010-08-10
ZA200404741B (en) 2005-08-29

Similar Documents

Publication Publication Date Title
AU1074702A (en) Sulfamides as gamma-secretase inhibitors
BG106020A (en) Inhibitors of impdh enzyme
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
DE60224189D1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
YU21702A (sh) Supstituisani indoli za moduliranje nfkb aktivnosti
ATE395912T1 (de) Dipeptidylpeptidase-hemmer für die behandlung oder prävention von diabetes
EP1562897A4 (en) PHENYL ACARBOXAMIDE AS A BETA SEKRETASE INHIBITOR FOR THE TREATMENT OF ALZHEIMER
ATE244717T1 (de) Inhibitoren des impdh-enzyms
SI1567488T1 (sl) Derivati hidroksietilamina za zdravljenje alzheimerjeve bolezni
IL165434A0 (en) Compounds having DPP-IV inhibitory activity
IL148903A0 (en) Certain alkylene diamine-substituted heterocycles
MXPA04005790A (es) Compuestos y usos de los mismos para reducir la actividad de la lipasa sensible a la hormona.
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
NO983688L (no) Serin-protease-inhibitorer
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
AU8647101A (en) Compounds having activity as inhibitors of cytochrome p450rai
AU1185801A (en) Novel compounds
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
MXPA06004308A (es) Isopentilcarboxanilidas para la lucha contra los microorganismos indeseables.
TW200612940A (en) Substituted tetrahydroisoquinolines as mmp inhibitors, process for their preparation and their use as medicament
MXPA04004743A (es) Derivados de 2,3-diaril-pirazolidina activos hacia neurotensina.
SI1244614T1 (en) Tryptase inhibitors
WO2003076429A3 (en) Azepane derivatives and their use as atk1 inhibitors
TW200503672A (en) 2-aminobenzoyl derivatives
RS20050421A (en) Aminoindazole derivatives and use thereof as kinase inhibitors

Legal Events

Date Code Title Description
FG Grant or registration